Bloomberg Anywhere Remote Login Bloomberg Terminal Demo Request


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Bloomberg Customers

February 07, 2016 11:06 AM ET


Company Overview of Ascenta Therapeutics, Inc.

Executive Profile

Marc Estes Lippman M.D.

Co-Founder and Director, Ascenta Therapeutics, Inc.
AgeTotal Calculated CompensationThis person is connected to 2 Board Members in 2 different organizations across 4 different industries.

See Board Relationships


Dr. Marc Estes Lippman, M.D., is the Co-Founder and Director of Ascenta Therapeutics, Inc. Dr. Loppman was a Senior Advisor of Perseus, L.L.C. He joined it in 1995. Dr. Lippman is a Deputy Director of The Sylvester Comprehensive Cancer Center since January 2010. He serves as the Chairperson of the Scientific Advisory Board for the Perseus-Soros Fund. In addition, Dr. Lippman serves as a Scientific and Clinical Advisor at Threshold Pharmaceuticals Inc. He has served ...

Corporate Headquarters

101 Lindenwood Drive
Malvern, Pennsylvania 19355

United States

Phone: 610-408-0301
Fax: 610-725-1515

Board Members Memberships

Co-Founder and Director
Director and Member of Nominating & Corporate Governance Committee


BA 1964
Cornell University
Yale University

Other Affiliations

Annual Compensation

There is no Annual Compensation data available.

Stocks Options

There is no Stock Options data available.

Total Compensation

There is no Total Compensation data available.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup


There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Ascenta Therapeutics, Inc., please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at